Friday - April 10, 2026

Chia Seeds Market Size to Reach USD 1.41 Billion by 2031, Supported by Plant-Based Nutrition Demand, Organic Premiumization, and Functional Food Expansion

Chia Seeds Market Size & Trends | Mordor Intelligence Explore the chia seeds market (2026–2031) with Mordor Intelligence. Get in-depth insights on market size, share, revenue, segments, key drivers, latest trends, and growth opportunities shaping the future of sustainable construction. … Continue reading

Organisational Intelligence Group Pty Ltd Expands Human-Centered Work Approach Led by Cassandra Gordon

Sydney, Australia – Organisational Intelligence Group Pty Ltd, led by strategist and advisor Cassandra Gordon, is expanding its human-centered approach as demand grows for more sustainable, aligned workplace systems. The move reflects a broader shift across industries, where professionals, customers, and … Continue reading

Global Obesity Pipeline Surges as 80+ Pharma Players Intensify Clinical Trials, Paving the Way for Next-Gen Weight Loss Therapies | DelveInsight

Obesity Pipelin Leading Obesity Companies include Zealand Pharma, Sciwind Biosciences, Genexine, Sirnaomics, Sparrow Pharmaceuticals, Shionogi, Regor Pharmaceuticals, Innovent Biologics, Pfizer, NodThera Limited, Boehringer Ingelheim, Fractyl Health, TransThera, Clearmind Medicine, PegBio, Biolingus, and others. DelveInsight’s “Obesity Pipeline Insight 2026” report provides … Continue reading

Myelodysplastic Syndrome Pipeline Surges as 120+ Pharma Players Accelerate Clinical Innovation and Transform Treatment Landscape by 2034 | DelveInsight

Myelodysplastic Syndrome Pipeline Leading Myelodysplastic Syndrome Companies such as Syros Pharmaceuticals, Curis, Ryvu Therapeutics, Chia Tai Tianqing Pharmaceutical Group, Amgen, Sanofi, Forma Therapeutics, Agios Pharmaceuticals, AbbVie, Daiichi Sankyo Company, Geron Corporation, Astex Pharmaceuticals, Jazz Pharmaceuticals, Maxinovel Pty., Ltd., Mabwell (Shanghai) … Continue reading

Hemophilia B Pipeline 2026 Report Highlights Next-Gen Gene Therapies, FDA Advances, and Clinical Momentum Across Novo Nordisk, Pfizer, Sanofi & Emerging Biotechs | DelveInsight

As per DelveInsight’s assessment, globally, Hemophilia B pipeline constitutes 15+ key companies continuously working towards developing 20+ Hemophilia B treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. As per DelveInsight’s assessment, … Continue reading